$165 Million is the total value of Worth Venture Partners, LLC's 204 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $12,336,000 | – | 6,833,000 | +100.0% | 6.87% | – | |
| New | HERBALIFE LTDnote 2.000% 8/1 | $6,231,000 | – | 5,000,000 | +100.0% | 3.47% | – | |
| New | RETROPHIN INCnote 2.500% 9/1 | $5,617,000 | – | 5,963,000 | +100.0% | 3.13% | – | |
| New | MEDICINES COnote 2.750% 7/1 | $4,494,000 | – | 5,326,000 | +100.0% | 2.50% | – | |
| BIIB | New | BIOGEN INC | $3,735,000 | – | 15,800 | +100.0% | 2.08% | – |
| AMGN | New | AMGEN INC | $2,384,000 | – | 12,548 | +100.0% | 1.33% | – |
| New | ZENDESK INCnote 0.250% 3/1 | $2,190,000 | – | 1,500,000 | +100.0% | 1.22% | – | |
| BKNG | New | BOOKING HOLDINGS ORD | $2,094,000 | – | 1,200 | +100.0% | 1.17% | – |
| AVID | New | AVID TECHNOLOGY INC | $1,888,000 | – | 253,487 | +100.0% | 1.05% | – |
| SILC | New | SILICOM LTDord | $1,199,000 | – | 31,335 | +100.0% | 0.67% | – |
| New | BIOGEN INCput | $1,176,000 | – | 15,800 | +100.0% | 0.66% | – | |
| New | XILINX INCcall | $722,000 | – | 42,500 | +100.0% | 0.40% | – | |
| RIG | New | TRANSOCEAN LTD | $635,000 | – | 73,000 | +100.0% | 0.35% | – |
| LJPC | New | LA JOLLA PHARMACEUTICAL CO | $615,000 | – | 95,607 | +100.0% | 0.34% | – |
| DERM | New | DERMIRA INC | $596,000 | – | 44,000 | +100.0% | 0.33% | – |
| CORV | New | CORREVIO PHARMA CORP | $544,000 | – | 172,066 | +100.0% | 0.30% | – |
| RFIL | New | RF INDS LTD | $516,000 | – | 76,572 | +100.0% | 0.29% | – |
| NNDM | New | NANO DIMENSION LTDspons adr | $486,000 | – | 1,462,974 | +100.0% | 0.27% | – |
| NLNK | New | NEWLINK GENETICS CORP | $475,000 | – | 245,649 | +100.0% | 0.26% | – |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $425,000 | – | 59,740 | +100.0% | 0.24% | – |
| APVO | New | APTEVO THERAPEUTICS INC | $387,000 | – | 429,000 | +100.0% | 0.22% | – |
| New | ISHARES TRput | $380,000 | – | 50,000 | +100.0% | 0.21% | – | |
| SAVA | New | CASSAVA SCIENCES ORD | $372,000 | – | 288,363 | +100.0% | 0.21% | – |
| TMDI | New | TITAN MEDICAL ORD | $321,000 | – | 114,886 | +100.0% | 0.18% | – |
| CHK | New | CHESAPEAKE ENERGY CORP | $307,000 | – | 99,200 | +100.0% | 0.17% | – |
| ATEN | New | A10 NETWORKS INC | $266,000 | – | 37,576 | +100.0% | 0.15% | – |
| VTGN | New | VISTAGEN THERAPEUTICS INC | $203,000 | – | 158,343 | +100.0% | 0.11% | – |
| IMGN | New | IMMUNOGEN INC | $145,000 | – | 53,382 | +100.0% | 0.08% | – |
| New | IMMUNOGEN INCput | $133,000 | – | 55,800 | +100.0% | 0.07% | – | |
| BNGOW | New | BIONANO GENOMICS EQY WARRANT WRNT 6.13 21 Sep 23*w exp 08/21/202 | $112,000 | – | 88,446 | +100.0% | 0.06% | – |
| New | AMGEN INCput | $105,000 | – | 38,000 | +100.0% | 0.06% | – | |
| New | RETROPHIN INCput | $84,000 | – | 19,179 | +100.0% | 0.05% | – | |
| IVAC | New | INTEVAC INC | $71,000 | – | 11,464 | +100.0% | 0.04% | – |
| New | BIOCRYST PHARMACEUTICALSput | $63,000 | – | 16,200 | +100.0% | 0.04% | – | |
| New | BIOMARIN PHARMACEUTICAL INCput | $55,000 | – | 6,611 | +100.0% | 0.03% | – | |
| New | BIOCRYST PHARMACEUTICALScall | $49,000 | – | 16,200 | +100.0% | 0.03% | – | |
| New | BOOKING HLDGS INCput | $46,000 | – | 208 | +100.0% | 0.03% | – | |
| New | CARA THERAPEUTICS INCcall | $35,000 | – | 15,900 | +100.0% | 0.02% | – | |
| New | ZAYO GROUP HLDGS INCcall | $33,000 | – | 40,000 | +100.0% | 0.02% | – | |
| ENTXW | New | ENTERA BIO LTD*w exp 06/27/202 | $13,000 | – | 13,943 | +100.0% | 0.01% | – |
| New | ABBVIE INCput | $7,000 | – | 22,500 | +100.0% | 0.00% | – | |
| New | HERBALIFE NUTRITION LTDput | $2,000 | – | 1,496 | +100.0% | 0.00% | – | |
| New | NOVAVAX INCcall | $2,000 | – | 43,500 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AIRGAIN ORD | 25 | Q3 2023 | 1.8% |
| PIXELWORKS ORD | 23 | Q3 2022 | 1.3% |
| SILICOM ORD | 22 | Q3 2023 | 1.8% |
| DSP GROUPS INC | 20 | Q3 2021 | 1.4% |
| DIGITAL TURBINE ORD | 19 | Q2 2023 | 1.0% |
| BK OF AMERICA CORP | 17 | Q3 2023 | 1.1% |
| EQUITY COMWLTH REIT ORD | 17 | Q3 2023 | 0.7% |
| ISHARES TR | 16 | Q4 2020 | 3.0% |
| SCPHARMACEUTICALS ORD | 16 | Q3 2023 | 2.8% |
| SELECT SECTOR SPDR TR | 16 | Q4 2020 | 1.3% |
View Worth Venture Partners, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-13 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-15 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
View Worth Venture Partners, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.